4.7 Article Proceedings Paper

Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

We should desist using RECIST, at least in GIST

Robert S. Benjamin et al.

JOURNAL OF CLINICAL ONCOLOGY (2007)

Article Oncology

State-of-the art therapy for gastrointestinal stromal tumors

CD Blanke et al.

CANCER INVESTIGATION (2005)

Article Medicine, General & Internal

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

GD Demetri et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)

Article Hematology

ARG tyrosine kinase activity is inhibited by ST1571

K Okuda et al.

Article Medicine, General & Internal

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.

H Joensuu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)